Shares of RadNet (NASDAQ:RDNT) remained unaffected at $14.43 after the company reported Q1 results.
Earnings per share fell 312.50% year over year to ($0.33), which missed the estimate of ($0.17).
Revenue of $281,564,000 up by 3.69% year over year, which beat the estimate of $258,420,000.
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: May 11, 2020
Time: 09:02 PM ET
Webcast URL: http://public.viavid.com/player/index.php?id=139286
52-week high: $23.45
52-week low: $5.81
Price action over last quarter: down 2.37%
RadNet Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The firm derives revenue from fees charged for the diagnostic imaging services performed at these centers.